CHICAGO – First Hospitality, a national hotel operating and development company, announces the promotion of four leaders ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

After 33 years of doing morning radio, Bob Rivers on August 8, 2014 decided to step away and discontinue The Bob Rivers Morning Show, exiting KJR-FM 95.7. It was his third Seattle radio home ...

Bob Rivers, the longtime Seattle radio host known for his irreverent humor, musical parodies and decadeslong run as a morning show fixture, died early Tuesday from complications of esophageal ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

After 33 years of doing morning radio, Bob Rivers decided to step away and discontinue The Bob Rivers Morning Show, exiting KJR-FM 95.7 in 2014. Now, many radio industry veterans are expressing ...

March 10 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and Mexico in the second half of ...

The list is based only on the players’ NFL careers, not their high school careers. Bob Lilly is our #4 ranked player. There is a clear top-four, and you can argue them in any order. Lilly was a ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture knockoff versions of Eli Lilly's tirzepatide while a lawsuit plays out.